Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BI-PACED: Antibiotic prophylaxis for CIED infection
NCT06448624Phase 4Completed
- Sponsor
- Diponegoro University
- Start
- Apr 2024
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ampicillin + sulbactam in Cardiac Implantable Electronic Device Infection (2 arms), sponsored by Diponegoro University. Primary endpoint: Incidence of CIED-related infection at 28 days. Started Apr 2024; status: completed.
02
Drugs
ampicillin + sulbactam
03
Conditions
Cardiac Implantable Electronic Device Infection
Beyond the preview
Go deeper on NCT06448624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06448624.